Description
This course will address the increased demand for prostate MRI, as prostate cancer diagnosis continues to rise in North American men. Multi-parametric sequences utilizing T2-weighted imaging, diffusion-weighted imaging (DWI), and dynamic contrast enhancement (DCE) have led to increased utilization of prostate MRI for detection, localization, staging, risk stratification, active surveillance, recurrence assessment, and guidance for targeted-biopsy and focal therapy. Radiologists will gain up-to-date information on the latest standards for prostate examination and mpMRI.
Learning Outcomes and Modules
After completing this course, the learner should be able to:
- Perform high quality multi-parametric prostate MRI.
- Interpret multi-parametric prostate MRI according to PI-RADSv2.1.
- Apply tips and recognize potential pitfalls that can mimic prostate cancer.
- Interpret post-treatment prostate MRI with PI-RR.
- Be familiar with local staging, focal therapies and PSMA PET.
Module 1
- Optimizing Technique and Maintaining Quality—Angela Tong, MS, MD
- PI-RADSv2.1 Case-Based Interpretation—Rajan Gupta, MD
- Pearls and Pitfalls—Silvia Chang, MD
- Local Staging: with a Focus on EPE or No EPE?—Antonio Westphalen, MD, PhD
Module 2
- PI-RR with Case-Based Interpretation—Kate Hanneman, MD, MPH
- Focal Therapy: What You Need to Know—Elsie T. Nguyen, MD, FRCPC
- PSMA PET: Where Are We and Where Are We Going?—Devaki Shilpa Surasi, MD
- Case Review—Sandeep Arora, MBBS
